Safety of sodium-glucose cotransporter 2 inhibitors (SGLT2i) during the month of Ramadan in patients with type 2 diabetes mellitus in Pakistani population—an …

A Sheikh, B Das, S Sattar, N Islam - Endocrine, 2023 - Springer
Background and aims Primary aim was to assess the safety of SGLT2-i in patients with Type
2 Diabetes Mellitus (T2D) in a real-life scenario during Ramadan by finding the frequency …

Efficacy and safety of empagliflozin in people with type 2 diabetes during Ramadan fasting

S Yousuf, MY Ahmedani - … & Metabolic Syndrome: Clinical Research & …, 2022 - Elsevier
Background and aims To explore efficacy and safety of empagliflozin in people with type2
diabetes during Ramadan fasting Methods People with type2 diabetes (T2DM) who were …

Safety and Tolerability of Sodium Glucose Co-Transporters-2 Inhibitors Among Elderly Patients with Type 2 Diabetes Fasting Ramadan

HA Ghazi - The Egyptian Journal of Hospital Medicine, 2023 - ejhm.journals.ekb.eg
Background: One of the main five pillars of Islam is Ramadan fasting and it may carry some
hazards on some patients especially elderly patients. Sodium Glucose Co-Transporter-2 …